Medical Weight Loss
We use use semaglutide (e.g., Wegovy, Ozempic) and tirzepatide (e.g., Mounjaro) for effective weight management.
What Are Semaglutide and Tirzepatide?
Semaglutide: Mimics GLP-1 (glucagon like peptides) hormone to reduce hunger. FDA-approved for weight loss under the name Wegovy and for diabetes as Ozempic.
Tirzepatide: Combines GLP-1 and GIP (glucose-dependent insulinotropic peptide) agonists. Primarily approved for Type 2 diabetes but shows significant weight-loss effects.
How Do These Medications Work for Weight Loss?
Appetite Suppression: Reduce hunger and cravings by acting on brain regions regulating satiety.
Slowed Digestion: Delay gastric emptying, making you feel full longer after meals.
Improved Insulin Sensitivity: Enhance glucose regulation, which supports fat loss and metabolic health.
Semaglutide Vs Tirzepatide
Feature
Semaglutide (Wegovy)
Tirzepatide (Mounjaro)
FAQ
Who Is Eligible for These Programs?
Ideal candidates include:
BMI ≥30: Obesity without other medical conditions.
BMI ≥27: Overweight with conditions like diabetes, hypertension, or high cholesterol.
Patients Struggling with Traditional Weight Loss: Difficulty losing weight through diet and exercise alone.
Reviews
Don’t just take our word for it